| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
37,951,000 |
| Market
Cap: |
110.82(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.14 - $6.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
3,866 |
101,896 |
| Total Buy Value |
$0 |
$0 |
$17,745 |
$794,229 |
| Total People Bought |
0 |
0 |
1 |
2 |
| Total Buy Transactions |
0 |
0 |
1 |
24 |
| Total Shares Sold |
54,626 |
154,300 |
154,300 |
154,300 |
| Total Sell Value |
$230,857 |
$849,128 |
$849,128 |
$849,128 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
15 |
27 |
27 |
27 |
| End Date |
2025-09-18 |
2025-06-17 |
2024-12-17 |
2023-12-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-12 |
4 |
S |
$3.26 |
$5,541 |
D/D |
(1,700) |
0 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-12 |
4 |
OE |
$0.06 |
$102 |
D/D |
1,700 |
1,700 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-11 |
4 |
S |
$3.24 |
$11,520 |
D/D |
(3,555) |
0 |
|
1% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-11 |
4 |
OE |
$0.06 |
$213 |
D/D |
3,555 |
3,555 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-10 |
4 |
S |
$3.35 |
$2,161 |
D/D |
(645) |
0 |
|
3% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-10 |
4 |
A |
$0.06 |
$39 |
D/D |
645 |
645 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-09 |
4 |
S |
$3.31 |
$1,988 |
D/D |
(600) |
0 |
|
6% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-09 |
4 |
OE |
$0.06 |
$36 |
D/D |
600 |
600 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-03 |
4 |
S |
$3.52 |
$17,623 |
D/D |
(5,000) |
0 |
|
10% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-03 |
4 |
OE |
$0.06 |
$300 |
D/D |
5,000 |
5,000 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-02 |
4 |
S |
$3.91 |
$5,858 |
D/D |
(1,500) |
0 |
|
18% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-12-02 |
4 |
OE |
$0.06 |
$90 |
D/D |
1,500 |
1,500 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-25 |
4 |
S |
$3.90 |
$23,264 |
D/D |
(5,965) |
5,965 |
|
20% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-25 |
4 |
OE |
$0.06 |
$358 |
D/D |
5,965 |
11,930 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-24 |
4 |
S |
$3.94 |
$2,105 |
D/D |
(535) |
0 |
|
17% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-24 |
4 |
OE |
$0.06 |
$32 |
D/D |
535 |
535 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-18 |
4 |
S |
$3.75 |
$24,402 |
D/D |
(6,500) |
0 |
|
17% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-18 |
4 |
OE |
$0.06 |
$390 |
D/D |
6,500 |
6,500 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-10 |
4 |
S |
$4.10 |
$26,650 |
D/D |
(6,500) |
0 |
|
22% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-10 |
4 |
OE |
$0.06 |
$390 |
D/D |
6,500 |
6,500 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-05 |
4 |
S |
$4.24 |
$14,408 |
D/D |
(3,398) |
0 |
|
28% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-05 |
4 |
OE |
$0.06 |
$204 |
D/D |
3,398 |
3,398 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-04 |
4 |
S |
$4.40 |
$13,634 |
D/D |
(3,102) |
0 |
|
28% |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-11-04 |
4 |
OE |
$0.06 |
$186 |
D/D |
3,102 |
3,102 |
|
- |
|
| Moreadith Randall |
Chief Scientific Officer |
• – – |
2025-10-28 |
4 |
S |
$4.96 |
$27,541 |
D/D |
(5,551) |
0 |
|
39% |
|
117 Records found
|
|
Page 1 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.07 (2.34%) 
